about
Mutation analysis of the CHK2 gene in breast carcinoma and other cancersFunctional Role of the microRNA-200 Family in Breast Morphogenesis and NeoplasiadeltaNp63 has a role in maintaining epithelial integrity in airway epitheliumCommon sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancerA variant associated with nicotine dependence, lung cancer and peripheral arterial diseaseThe BARD1 Cys557Ser variant and breast cancer risk in IcelandA genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes.Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age.Sequence variant on 8q24 confers susceptibility to urinary bladder cancer.Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populationsEpithelial Plasticity During Human Breast Morphogenesis and Cancer Progression.MicroRNA-200c-141 and ∆Np63 are required for breast epithelial differentiation and branching morphogenesis.Endothelial-rich microenvironment supports growth and branching morphogenesis of prostate epithelial cells.A population-based analysis of increased incidence and improved survival of testicular cancer patients in Iceland.Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits.High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer.Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.A common variant associated with prostate cancer in European and African populations.Chromosome imbalance at the 3p14 region in human breast tumours: high frequency in patients with inherited predisposition due to BRCA2.Mutations of the BRCA1 and BRCA2 Genes in Danish Patients Diagnosed at Young Age with Multi-Centric or Bilateral Breast Cancer.Two variants on chromosome 17 confer prostate cancer risk and the one in TCF2 protects against type 2 diabetesCommon variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancerTesticular germ cell tumours in IcelandAnalysis of HPC1, HPCX, and PCaP in Icelandic hereditary prostate cancerThe effect of mismatch repair deficiency on tumourigenesis; microsatellite instability affecting genes containing short repeated sequencesReplication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variablesIdentification of a novel splice-site mutation of the BRCA1 gene in two breast cancer families: screening reveals low frequency in Icelandic breast cancer patientsHigh prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patientsLoss of heterozygosity on chromosome 9 in human breast cancer: Association with clinical variables and genetic changes at other chromosome regionsDifferent tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13Linkage analysis and allelic imbalance in human breast cancer kindreds using microsatellite markers from the short arm of chromosome 3Identification of a breast tumor with microsatellite instability in a potential carrier of the hereditary non-polyposis colon cancer traitMapping of chromosome-3 alterations in human breast-cancer using microsatellite PCR markers - correlation with clinical-variables
P50
Q24807365-E44F4993-9EC4-4F22-8DEA-432298D08320Q26861636-E3AE5E06-9CE8-40E7-8459-F2952A58BF0CQ27322351-CEA460F9-FE7A-4C2D-8D45-35F734D616F4Q28943505-98B562AB-E3A8-41D7-856E-B09927318BFFQ29614871-F6675D14-D171-4DB4-856E-A38D8EE5BD24Q33246499-B878F79E-19FB-4AD9-A075-8347DF1D66F4Q34122344-3E430AB9-CAF2-4C61-95F6-6EAE0C11ACA1Q34631785-6EBDD8FA-6BA2-48DB-969B-C85F59814AAFQ35437468-94F14908-48E3-47F0-973A-640C1F5A39ACQ35964294-BB49CF16-4DD8-4371-8366-BF2E93E2CB7AQ36878530-D7FAC693-0509-4993-B28C-1FA2A1034C62Q37507345-6A1E4137-9C23-4A74-9C52-EA1513C5C2C6Q38875840-943586C2-5C61-4A4A-AE59-9DC1F987739EQ39218007-A8F01F9E-A64F-4912-8BB7-05815272DF22Q40565770-1CEE8A63-0111-4483-A896-6845FF41FB97Q42442996-369A8A72-C8D5-4DF8-87CF-6615BCF1C9F7Q43935128-24669CA4-BF6E-4C47-AA98-3858C660BD27Q46332214-D32BC033-C5BA-48D2-BC80-D791761C1B2DQ46921392-C1EC71CF-4300-4776-814F-6D7C4297F191Q47981696-101D55DD-5168-4D03-A307-E5C1E14DF30BQ55601290-0322F4A5-8DD5-4FD5-855B-A6274E162F44Q56968912-F370722A-9688-4427-B4C4-03B10FA8F9DDQ57251792-0734280E-7683-4EB5-9B67-386739BA534AQ57419173-B268C36A-721E-4145-9C20-83B8EA93CD20Q57419178-1D1B85E6-DC09-4BE5-8EF7-A0575A35519DQ57419179-1E5E8AB8-C574-4DAB-9624-09976580196FQ57419180-15E3A5D9-DA9B-48F8-AD08-643F68EC850CQ57419183-4E5819FD-3DE7-4428-8113-293BB255C6BBQ57419184-DC4D2533-A964-41BB-AD57-22DB50206279Q57419186-97507E13-32FE-4415-B302-D596FFA2109BQ57419190-7B23941A-E381-4DB5-9259-8EB324C9130EQ57419193-D638DC9B-498E-433B-BE64-8AE1D6B4B947Q57419198-23BB8C90-2279-4CCC-9B17-188580C65ED4Q57419203-9D777D19-A310-4A4F-8C08-E6D28EA2109E
P50
description
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Jon T Bergthorsson
@ast
Jon T Bergthorsson
@en
Jon T Bergthorsson
@es
Jon T Bergthorsson
@nl
Jon T Bergthorsson
@sl
type
label
Jon T Bergthorsson
@ast
Jon T Bergthorsson
@en
Jon T Bergthorsson
@es
Jon T Bergthorsson
@nl
Jon T Bergthorsson
@sl
prefLabel
Jon T Bergthorsson
@ast
Jon T Bergthorsson
@en
Jon T Bergthorsson
@es
Jon T Bergthorsson
@nl
Jon T Bergthorsson
@sl
P106
P21
P214
251152138681210982657
P31
P496
0000-0002-0560-2639